Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root

Updated on: February 18,2024

Study sheds light on how breast cancer cells evade immune surveillance and survive in lymph nodes

by Brandon Chase,Massachusetts General HospitalA molecule called MHC-II (seen here in green) disguises metastatic breast cancer cells (red), allowing them to invade the lymph nodes and take root

Updated on:February 18,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b

Updated on: March 20,2024

RNA-based therapy shows promise against aggressive childhood brain tumors in mice

by Johns Hopkins UniversityCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2024.113938Targeting a non-encoding stretch of RNA may help shrink tumors caused by an aggressive type of b

Updated on:March 20,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on: February 23,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on:February 23,2024

Real-time reconstruction of high-intensity focused ultrasound focal temperature field based on deep learning

by BMEF (BME Frontiers)Invivoreal-time temperature field reconstruction during HIFU treatment using deep learning. Credit: School of Integrated Circuits @ HUST.High-intensity focused ultrasound

Updated on: March 30,2024

Real-time reconstruction of high-intensity focused ultrasound focal temperature field based on deep learning

by BMEF (BME Frontiers)Invivoreal-time temperature field reconstruction during HIFU treatment using deep learning. Credit: School of Integrated Circuits @ HUST.High-intensity focused ultrasound

Updated on:March 30,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on: April 09,2024

Therapeutic vaccine shows promise against a range of cancers

by Serena Gordon, Healthday Reporter(HealthDay)—A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, rese

Updated on:April 09,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on: February 20,2024

COVID-19 booster vaccine doses strengthen immunity in blood cancer patients, shows study

by University of SouthamptonCredit: Pixabay/CC0 Public DomainResearch by the University of Southampton into the effectiveness of COVID-19 vaccines in people with lymphoma has shown that repeated

Updated on:February 20,2024

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on: February 20,2024

Experimental drug to treat liver cancer shows evidence of activity with manageable side effects

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainA new drug that inhibits an enzyme playing a crucial role in cell division and growth has shown signs of a

Updated on:February 20,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on: January 11,2024

New delivery strategy may improve chemotherapy for acute myeloid leukemia

byWileyCNL augments the efficacy of cytarabine/venetoclax treatment in in vivo AML models. (A–C) Bioluminescence images (A), their quantification (B) and survival of MOLM-13 Luc-YFP bearing NRG

Updated on:January 11,2024

Study sheds light on mechanisms underlying H. pylori-induced gastric cancer

by Juntendo University Research Promotion CenterThe disruption of Wnt/PCP signaling by the oncoprotein CagA seems to promote gastric carcinogenesis. Credit: Atsushi Takahashi-Kanemitsu, Juntendo Unive

Updated on: February 20,2024

Study sheds light on mechanisms underlying H. pylori-induced gastric cancer

by Juntendo University Research Promotion CenterThe disruption of Wnt/PCP signaling by the oncoprotein CagA seems to promote gastric carcinogenesis. Credit: Atsushi Takahashi-Kanemitsu, Juntendo Unive

Updated on:February 20,2024